Véronique Zennou

This inventor holds 13 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2000-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Véronique Zennou. Retrieved from https://idiyas.com/inventor/veronique-zennou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 7.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 90(Granted Patents)

Location History:

Creteil, FR (2000)
Paris, FR (2011 - 2014)
New York, NY (US) (2016 - 2019)

Company Filing History:

Centre National De La Recherche Scientifique

patents

9 out of 1,853

National Institute of Health and Medical Research

patents

4. 1 out of 2

Institut National De La Santéde La Recherche Médicale

patents

where one patent can have more than one assignee

Years Active: 2000-2019

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10407695 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2019-09-10),

2. 9238824 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2016-01-19),

3. 8652807 - Lentiviral vectors for the preparation of immunotherapeutical compositions (2014-02-18),

4. 8512994 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2013-08-20),

5. 8512993 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2013-08-20),

6. 8460678 - Use of triplex structure DNA in transferring nucleotide sequences (2013-06-11),

7. 8450087 - Use of triplex structure DNA in transferring nucleotide sequences (2013-05-28),

8. 8367068 - Use of triplex structure DNA in transferring nucleotide sequences (2013-02-05),

9. 8349606 - Lentiviral vectors for the preparation of immunotherapeutical compositions (2013-01-08),

10. 8093042 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2012-01-10),

11. 7981671 - Use of triplex structure DNA in transferring nucleotide sequences (2011-07-19),

12. 7968332 - Lentiviral vectors for the preparation of immunotherapeutical compositions (2011-06-28),

13. 6103462 - Rapid single-cycle assay for human immunodeficiency virus type-1 drug (2000-08-15),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.